Hims & Hers Health Inc. buy Guggenheim
Start price
27.02.24
/
50%
€12.65
Target price
27.02.25
€15.66
Performance (%)
208.38%
End price
28.02.25
€39.01
Summary
This prediction ended on 28.02.25 with a price of €39.01. With a performance of 208.38% the BUY prediction by Guggenheim was a big success. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Hims & Hers Health Inc. | 8.373% | 8.373% | -25.010% |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% |
Comments by Guggenheim for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Guggenheim from $15.00 to $17.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat
In the thread Trading Hims & Hers Health Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Guggenheim for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€11.00
28.02.23
28.02.23
€14.12
28.02.24
28.02.24
12.73%
29.02.24
29.02.24

